Zobrazeno 1 - 10
of 22
pro vyhledávání: '"S Bonicatto"'
Autor:
F. M. Delgado, F. Coppola, Cesar Blajman, A. Alvarez, L. Fein, R. Chacon, S. Bonicatto, J. Block, A. Schmilovich, L. Balbiani
Publikováno v:
Cancer. 85:1091-1097
BACKGROUND A prospective, multicenter, randomized, Phase III trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) with a combination of vinorelbine and doxorubicin (NA) in the treatment
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C, Blajman, L, Balbiani, J, Block, F, Coppola, R, Chacon, L, Fein, S, Bonicatto, A, Alvarez, A, Schmilovich, F M, Delgado
Publikováno v:
Cancer. 85(5)
A prospective, multicenter, randomized, Phase III trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) with a combination of vinorelbine and doxorubicin (NA) in the treatment of patient
Publikováno v:
Social psychiatry and psychiatric epidemiology. 32(6)
Quantitative models to explore behavioural disorders are being used increasingly often for health care decision making. Unfortunately, there is a dearth of instruments in Argentina specifically designed for our population, and few researchers have fo
Autor:
A. Figueredo, C. Chiaramello, M. Lavezzaro, E. Troncoso, E. Carinci, A. Barbero, L. Reuter, A. Mainella, Y. Burgos, S. Bonicatto
Publikováno v:
Journal of Clinical Oncology. 26:20540-20540
20540 Background: PN occurs in almost 10% of cancer patients(pts). Tumours associated are lung, breast, gynaecological cancers, and lymphoma. The clinical findings are heterogeneous and the pathoge...
Publikováno v:
Journal of Clinical Oncology. 24:18558-18558
18558 Background: Adition of D to the standard antiemetic treatment for CINV prevention is frequent, despite the lack of benefit evidence in controlled clinical trials. In this study we compare the impact of O treatment with or without D on daily lif
Publikováno v:
Journal of Clinical Oncology. 24:14120-14120
14120 Background: Over 50% of patients (pts) with obstructive carcinoma are inoperable at the time of the diagnosis and only 18% of them survive beyond a year. Palliative treatment must be quickly effective, safe, well tolerated and focused to reliev
Publikováno v:
Journal of Clinical Oncology. 24:15546-15546
15546 Background: ENB is a rare embrionary tumor derived from neuroblasts of the olfactory sensory system. Polypoid mass with epistaxis or nasal obstruction are the most common clinical manifestations of this tumor. It’s invasive and it frequently
Autor:
M. Andrada, P. Alvarez, D. Lewi, N. Villagra, S. Alberto, N. Mohr, G. Fiore, E. Korbenfeld, L. Kaen, S. Bonicatto
Publikováno v:
Lung Cancer. 49:S237
Autor:
M Gelemur, J De La Cruz, R Ferreras, N Giacomi, S Bonicatto, C Ivulich, G Cichetti, M Riva, L Ferreyra
Publikováno v:
Value in Health. 3:132